Press Releases
23 July 2019
HOUSTON, July 23, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced the European Patent Office has issued the decision t
Read more...WELLINGTON, New Zealand, July 23, 2019 /PRNewswire/ -- Volpara Solutions and
Read more...23 July 2019
SAN FRANCISCO, July 23, 2019 /PRNewswire/ -- Doximity, the professional medical network, today announced the release of its 2019-2020 Residency Navigator. Residency Navigator is the most compreh
Read more...23 July 2019
CARY, N.C. and LONDON, July 23, 2019 /PRNewswire/ -- PeriGen, the global leader in developing artificial intelligence (AI) systems for obstetrics, has partnered with specialist insurer Beazley to o
Read more...KELOWNA, British Columbia, July 23, 2019 /PRNewswire/ -- Valiant Recovery Inc. today announced that in recognition of their 10th Anniversary, they are offering Two Free full 30 day
Read more...SUNNYVALE, Calif., July 23, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today provided an update on the operational progress of its China joint venture, CNNC Accuray (Tianjin) Medical Technology Co., Ltd (CNNC Accuray). CNNC Accuray has received the Radiation Safety License from the China Min
Read more...SAN FRANCISCO, July 23, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2019 financi
Read more...23 July 2019
CHARLOTTE, N.C., July 23, 2019 /PRNewswire/ -- Sandal season exposes feet to a host of bacteria and fungus, and men, in particular, need at-home pedicures and Epsom salt foot soaks, Dr.
Read more...23 July 2019
LONDON and SALT LAKE CITY, July 23, 2019 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HK
Read more...BOSTON, July 23, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced the appointment of Geof
Read more...